Cg. Wu et al., INCREASED HEPATIC FERRITIN-H MESSENGER-RNA LEVELS CORRELATE WITH THOSE OF C-MYC IN HUMAN HEPATOCELLULAR-CARCINOMA, International journal of oncology, 11(1), 1997, pp. 187-192
Serum ferritin is elevated in many cancers. Using the subtraction-enha
nced display technique, we isolated several cDNA clones including ferr
itin-H which is overexpressed in rat hepatocellular carcinoma (HCC) in
duced by diethylnitrosamine. We investigated hepatic messenger RNA (mR
NA) levels of ferritin-H in patients with HCC, adenoma, cirrhosis and
healthy controls in relation to those of oncogene c-myc. Ferritin-H mR
NA levels were 2-12 fold higher in tumor tissues than in adjacent non-
tumor tissues in 12 of 17 patients with HCC, irrespective of coexistin
g cirrhosis or viral hepatitis. However, no difference in ferritin-H m
RNA levels was found in patients with adenoma, cirrhosis and healthy c
ontrols. c-myc mRNA levels were 2-5 ford increased in 11 of 17 HCC pat
ients, and correlated significantly with those of ferritin-H (p<0.001)
. In situ hybridization showed that the overexpressed ferritin-H mRNA
was restricted to the tumor nodules in HCC livers. These findings sugg
est that overexpression of ferritin-fl in HCC patients, correlated wit
h c-myc, is phenotypically associated with HCC, and could become a use
ful molecular indicator for human HCC.